cannabis products
  • Tilray Brands’ (TLRY) medical cannabis division, Tilray Medical, has received approval to commercialize its medical cannabis products in Poland
  • The approval allows Tilray Medical to expand its product offering and distribution across pharmacies in Europe
  • In Poland, Tilray Medical has established multiple partnerships with pharmaceutical companies to distribute both Tilray branded and unbranded medical cannabis products
  • Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis
  • Tilray Stock (TSX:TLRY) is up 1.30 per cent, trading at C$5.46 per share at 1:04 pm ET

Tilray Brands’ (TLRY) medical cannabis division, Tilray Medical, has received approval to commercialize its medical cannabis products in Poland.

The approval allows Tilray Medical to expand its product offering and distribution across pharmacies in Europe.

Denise Faltischek, Chief Strategy Officer and Head of International Business of Tilray commented on the news.

“I’m extremely proud of our team for once again expanding our approved authorization for Tilray Medical products across Europe. Tilray will continue to advocate for reasonable patient access to reliable and high-quality medical cannabis in Europe and countries around the world.”

Tilray Medical is a leading international provider of EU-GMP certified medical cannabis products in 21 countries. It has a comprehensive portfolio of trusted and reliable THC and CBD products each with a unique profile of cannabinoids and terpenes. 

Tilray Medical has established multiple partnerships with pharmaceutical companies in Poland to distribute Tilray branded and unbranded medical cannabis products. Patients may obtain prescriptions for medical cannabis in Poland through their preferred medical doctor.

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. Tilray Medical is one of the biggest suppliers of medical cannabis brands to patients, physicians, hospitals, pharmacies, researchers, and governments, in 21 countries and across five continents.


More From The Market Online

Canopy Growth fuels turnaround story with fresh capital

Canopy Growth (TSX:WEED) continues its turnaround story with a C$96.3 million exchange and subscription deal with an institutional investor.

Tilray’s 10 Barrel Brewing introduces new Mexican-style lagers

Tilray Brands (TSX:TLRY) subsidiary 10 Barrel Brewing unveils its latest creation: Pub Cerveza, a southern spirit in a Mexican-style lager.

The Market Online’s Weekly Cannabis Report – May 3, 2024

A federally licensed cultivator has received CUMCS-G.A.P and GACP certification for its cultivation facility in Ontario.

One of the strongest contenders to lead Canada’s cannabis market

Indiva Ltd. (TSXV:NDVA) recently reported its fiscal year 2023 results, showcasing a solid performance across its operations.